A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Clinical trial NCT04503265 · RECRUITING

Trial details

NCT number: NCT04503265
Sponsor: AtlasMedx, Incorporated
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Neoplasm Breast Cancer Ovarian Cancer Homologous Recombination Deficiency Prostate Cancer Pancreatic Cancer

Start date: 2020-08-12
Primary completion: 2026-08-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.